CHECKMATE-77T

NCT04025879 📎

Regimen

Experimental
neoadj nivo+chemo → adjuvant nivo
Control
neoadj chemo → placebo

Population

Resectable stage IIA-IIIB NSCLC

Key finding

EFS HR 0.58 (0.42-0.81); pCR 25.3% vs 4.7%; nivo perioperative confirmed

Source: PMID 38749033

Timeline

  • Enrollment start: 2019-11-05 📎

Guideline citations

  • NCCN NSCLC Version 5.2026 (p.14)
  • CSCO NSCLC 2025 ⚠️ OCR source